%PDF-1.6
%
1 0 obj
<< /Lang (de) /MarkInfo << /Marked true >> /Metadata 3 0 R /Outlines 5 0 R /PageLayout /OneColumn /PageMode /UseOutlines /Pages 73 0 R /StructTreeRoot 75 0 R /Type /Catalog >>
endobj
2 0 obj
<< /Author (Pfizer-Pharma GmbH) /Company (Pfizer Inc) /CreationDate (D:20120523221109+02'00') /Creator (Acrobat PDFMaker 10.1 fr Word) /ModDate (D:20120523221332+02'00') /Producer (Adobe PDF Library 10.0) /SourceModified (D:20120523201059) /Subject (Gebrauchsinformationen) /Title (sab simplex 69,19 mg/ml Suspension zum Einnehmen) >>
endobj
3 0 obj
<< /Subtype /XML /Type /Metadata /Length 4232 >>
stream
2012-05-23T22:13:32+02:00
2012-05-23T22:11:09+02:00
2012-05-23T22:13:32+02:00
Acrobat PDFMaker 10.1 für Word
uuid:b181d61a-47b4-4a91-9952-d6fbcc0c3882
uuid:74807386-487a-454f-8621-46c963a2ee88
4
application/pdf
sab simplex 69,19 mg/ml Suspension zum Einnehmen
Pfizer-Pharma GmbH
Gebrauchsinformationen
Adobe PDF Library 10.0
D:20120523201059
Pfizer Inc
endstream
endobj
4 0 obj
<< /Type /ObjStm /Length 1720 /Filter /FlateDecode /N 67 /First 515 >>
stream
xXnF+^I
+ #X^8gHC
$Grt!I-v g^zU]MEiR1F qSJibIʼn1iBc$&Hk딘?X2